• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Human Chikungunya Virus IgG ELISA Kit

Scan QR to view Datasheet
Catalog # MBS495199
Unit / Price
  96 Tests  /  $890 +1 FREE 8GB USB
Chikungunya Virus IgG elisa kit
Product Name

Chikungunya Virus IgG, ELISA Kit

Popular Item
Also Known As

Human Chikungunya Virus IgG Capture ELISA Kit

Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Request for Current Manual Insert
Species Reactivity
Specificity
The specificity is defined as the probability of the assay of scoring negative -in the absence of the specific analyte. negative samples have been tested. The specificity is > 90%.
Samples
Human serum or plasma (citrate).
Sensitivity
> 90%.
Preparation and Storage
Storage 2 - 8 degree C
Product Note
Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual.
Other Notes
Small volumes of Chikungunya Virus IgG elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms forChikungunya Virus IgGpurchase
MBS495199 is a ready-to-use microwell, strip-or-full plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the Chikungunya Virus IgG, ELISA Kit target analytes in biological samples. The concentration gradients of the kit standards or positive controls render a theoretical kit detection range in biological research samples containing Chikungunya Virus IgG. The ELISA analytical biochemical technique of the MBS495199 kit is based on Chikungunya Virus IgG antibody-Chikungunya Virus IgG antigen interactions (immunosorbency) and an HRP colorimetric detection system to detect Chikungunya Virus IgG antigen targets in samples. The ELISA Kit is designed to detect native, not recombinant, Chikungunya Virus IgG. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, secretions. Quality control assays assessing reproducibility identified the intra-assay CV (%) and inter-assay CV(%).
Related Product Information for
Chikungunya Virus IgG elisa kit
Principle of the Assay: The Chikungunya IgG-ELISA is intended for the determination of IgG class antibodies to Chikungunya in human serum or plasma (citrate).

Background: Chikungunya virus is an arthropod borne virus of the genus Alphavirus (family Togaviridae). The AIphavirus genus contains at least 24 distinct species. These are lipid-enveloped virions with a diameter of 50 to 60 nm. Alphavirus infections are initiated by the bite of an infected mosquito, which results in the deposition of virus in subcutaneous and possibly cutaneous tissues. After an incubation period of 1 to 12 days the Chikungunya fever develops. Chikungunya fever (Chikungunya means "that which bends up", in reference to the crippling manifestations of the disease) is an acute viral infection characterized by a rapid transition from a state of good health to illness that includes severe arthralgia and fever. Temperature rises abruptly to as high as 40·C and is often accompanied by shaking chills. After a few days, fever may abate and recrudesce, giving rise to a "saddleback" fever curve. Arthralgia is polyarticular, favoring the small joints and sites of previous injuries, and is most intense on arising. Subjects typically avoid movement as much as possible. Joints may swell without significant fluid acc- umulations. These symptoms may last from 1 week to several months ·and are accompanied by myalg- ia. The rash characteristically appears on the first day of illness, but onset may be delayed. It usually arises as a flush over the face and neck, which evolves to a maculopapular or macular form that may be pruritic. The latter lesions appear on the trunk, limbs, face, plams and soles, in that order of frequency. Petechial skin lesions have also been noted. Headache, photophobia, retro-orbitral pain, sore throat with objective signs of pharyngitis, nausea and vomiting also occur in this setting. Occasionally, however persistent arthralgia and polyarthritis (lasting months or even years) do occur, sometimes involving joint destruction. Even rarer, sequelae include encephalitis and meningoencephalitis with.high lethality rates. The virus has major importance in Africa and Asia. From 20% to more than 90% of the population of tropical and subtropical show serologic evidence of infection. Because Aedes mosquitoes are increasingly prevalent in North Africa and South America, where the population would be uniformly susceptible to infection, the possibility for epidemics is evident. Chikungunya virus infections are imported to central Europe mainly by travellers to tropical and subtropical countries.
Sample Manual Insert of MBS495199. Click to request current manual
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000